NPI: 1174598981 · BRANFORD, CT 06405 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/23/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/23/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,013 | $330K |
| 2019 | 21,011 | $178K |
| 2020 | 13,370 | $93K |
| 2021 | 9,928 | $119K |
| 2022 | 10,207 | $233K |
| 2023 | 3,416 | $132K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,264 | 2,081 | $572K |
| 83970 | 1,134 | 950 | $197K | |
| 82728 | 606 | 526 | $70K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 22,550 | 1,138 | $69K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 2,508 | 1,081 | $50K |
| 83550 | 539 | 461 | $33K | |
| 83540 | 602 | 513 | $28K | |
| 82108 | 117 | 109 | $21K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,644 | 920 | $15K |
| A4657 | Syringe, with or without needle, each | 1,492 | 1,303 | $9K |
| J1756 | Injection, iron sucrose, 1 mg | 4,317 | 1,060 | $7K |
| 85041 | 1,284 | 1,123 | $6K | |
| 85048 | 1,178 | 1,025 | $5K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 69 | 36 | $2K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 580 | 97 | $2K |
| 90662 | 12 | 12 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 49 | 45 | $0.00 |